Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.31M

combined est. value

Stock	Shares	Price	Value	Weight	As of
MIRMMirum Pharmaceuticals, Inc.	10,727	$122.13	$1.31M	100%	2026-05-29

MIRM

Mirum Pharmaceuticals, Inc.

$1.31M

10,727 sh

Activity

Open-market buy & sell volume

BuySell

Total +$553.9K bought

Most bought

ADVM

$553.9K

All filings on record

Every Form 4 transaction we track for this filer

all 8buys 2sells 0

Stock	Transaction	Date	~6mo later
MIRMMirum Pharmaceuticals, Inc.	Exercise — · 3,977 sh	2026-05-29	—
ADVMAdverum Biotechnologies, Inc.	Other — · 522,666 sh	2025-12-09	—
ADVMAdverum Biotechnologies, Inc.	Grant — · 500,000 sh	2025-12-09	—
ADVMAdverum Biotechnologies, Inc.	Other — · 25,000 sh	2025-12-09	—
ADVMAdverum Biotechnologies, Inc.	Other — · 351,513 sh	2025-12-09	—
ADVMAdverum Biotechnologies, Inc.	Exercise $630.0K · 150,000 sh	2025-12-09	—
ADVMAdverum Biotechnologies, Inc.	Buy $506.9K · 117,614 sh	2025-12-08	—
ADVMAdverum Biotechnologies, Inc.	Buy $47.0K · 11,085 sh	2025-12-05	—

MIRMExercise

2026-05-29 · Mirum Pharmaceuticals, Inc.

3,977

—

ADVMOther

2025-12-09 · Adverum Biotechnologies, Inc.

522,666

—

ADVMGrant

2025-12-09 · Adverum Biotechnologies, Inc.

500,000

—

ADVMOther

2025-12-09 · Adverum Biotechnologies, Inc.

25,000

—

ADVMOther

2025-12-09 · Adverum Biotechnologies, Inc.

351,513

—

ADVMExercise

2025-12-09 · Adverum Biotechnologies, Inc.

$630.0K

—

ADVMBuy

2025-12-08 · Adverum Biotechnologies, Inc.

$506.9K

—

ADVMBuy

2025-12-05 · Adverum Biotechnologies, Inc.

$47.0K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.